AVAI BIO, INC. Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments
AVAI BIO, INC. (AVAI) reported Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments of -$2.97 thousand for the 12-month period ending 2023-03-31, per its 10-K/A filed 2023-07-13.
Discontinued › Notes › Goodwill and Other
us-gaap:FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments · last filed 2024-02-14
- AVAI BIO, INC. finite-lived intangible assets, translation and purchase accounting adjustments for the quarter ending 2022-12-31 was -$9.19K.
- AVAI BIO, INC. finite-lived intangible assets, translation and purchase accounting adjustments for the quarter ending 2022-09-30 was $10.96K.
- AVAI BIO, INC. finite-lived intangible assets, translation and purchase accounting adjustments for the quarter ending 2022-06-30 was -$4.69K.
- AVAI BIO, INC. finite-lived intangible assets, translation and purchase accounting adjustments for the quarter ending 2021-12-31 was -$1.58K, a 116.14% decline year-over-year.
- AVAI BIO, INC. finite-lived intangible assets, translation and purchase accounting adjustments for fiscal 2023 was -$2.97K.
- AVAI BIO, INC. finite-lived intangible assets, translation and purchase accounting adjustments for fiscal 2022 was -$11.63K, a 202.06% decline from fiscal 2021.
- AVAI BIO, INC. finite-lived intangible assets, translation and purchase accounting adjustments for fiscal 2021 was $11.39K.
| Period end | Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments 3 month | Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments 6 month | Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments 9 month | Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$2.97K 10-K/A · filed 2023-07-13 | |||
| 2022-12-31 | -$9.19K 10-Q · filed 2024-02-14 | $1.77K derived: sum of 2 quarters · filed 2024-02-14 | -$2.92K derived: sum of 3 quarters · filed 2024-02-14 | |
| 2022-09-30 | $10.96K 10-Q · filed 2024-02-14 | $6.26K derived: sum of 2 quarters · filed 2024-02-14 | ||
| 2022-06-30 | -$4.69K 10-Q · filed 2024-02-14 | |||
| 2022-03-31 | -$11.63K 10-K/A · filed 2023-07-13 | |||
| 2021-12-31 | -$1.58K 10-Q · filed 2023-02-14 | -$28.55K derived: sum of 2 quarters · filed 2023-02-14 | -$30.20K derived: sum of 3 quarters · filed 2023-02-14 | |
| 2021-09-30 | -$26.97K 10-Q · filed 2023-02-14 | -$28.62K derived: sum of 2 quarters · filed 2023-02-14 | ||
| 2021-06-30 | -$1.65K 10-Q · filed 2023-02-14 | |||
| 2021-03-31 | $11.39K 10-K · filed 2022-06-29 | |||
| 2020-12-31 | $9.81K 10-Q · filed 2022-02-14 | $18.01K derived: sum of 2 quarters · filed 2022-02-14 | $20.41K derived: sum of 3 quarters · filed 2022-02-14 | |
| 2020-09-30 | $8.20K 10-Q · filed 2022-02-14 | $10.60K derived: sum of 2 quarters · filed 2022-02-14 | ||
| 2020-06-30 | $2.40K 10-Q · filed 2022-02-14 |